Product Description: Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]WHO Drug Information - Volume 35, No. 2. 30 July 2021.